Skip to main content

Copaxone Side Effects

Generic name: glatiramer

Medically reviewed by Drugs.com. Last updated on Mar 4, 2023.

Note: This document contains side effect information about glatiramer. Some dosage forms listed on this page may not apply to the brand name Copaxone.

Applies to glatiramer: subcutaneous solution.

Serious side effects of Copaxone

Along with its needed effects, glatiramer (the active ingredient contained in Copaxone) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking glatiramer:

More common

Less common

Rare

Incidence not known

Other side effects of Copaxone

Some side effects of glatiramer may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

Less common

For Healthcare Professionals

Applies to glatiramer: subcutaneous kit, subcutaneous powder for injection, subcutaneous solution.

Local

Very common (10% or more): Injection site erythema (43%), injection site pain (40%), injection site pruritus (27%), injection site mass (26%), injection site edema (19%)

Common (1% to 10%): Injection site inflammation, injection site reaction, injection site hypersensitivity, injection site fibrosis, injection site atrophy

Uncommon (0.1% to 1%): Injection site hematoma, injection site abscess, injection site hypertrophy, injection site melanosis[Ref]

Cardiovascular

Very common (10% or more): Vasodilation (20%), chest pain (13%)

Common (1% to 10%): Palpitations, tachycardia, hypertension

Uncommon (0.1% to 1%): Hypotension, midsystolic click, systolic murmur, atrial fibrillation, bradycardia, fourth heart sound, postural hypotension, varicose veins, warts, dry skin

Postmarketing reports: Thrombosis, peripheral vascular disease, pericardial effusion, myocardial infarct, deep thrombophlebitis, coronary occlusion, congestive heart failure, cardiomyopathy, cardiomegaly, arrhythmia, angina pectoris[Ref]

Hematologic

Common (1% to 10%): Lymphadenopathy

Uncommon (0.1% to 1%): Leukopenia, anemia, cyanosis, eosinophilia, hematemesis, lymphedema, pancytopenia, splenomegaly[Ref]

Gastrointestinal

Very common (10% or more): Nausea (15%)

Common (1% to 10%): Vomiting, dysphagia, gastroenteritis

Uncommon (0.1% to 1%): Dry mouth, stomatitis, burning sensation on tongue, cholecystitis, colitis, esophageal ulcer, esophagitis, gastrointestinal carcinoma, gum hemorrhage, increased appetite, melena, mouth ulceration, pancreas disorder, pancreatitis, rectal hemorrhage, tenesmus, tongue discoloration, duodenal ulcer, circumoral paresthesia[Ref]

Respiratory

Very common (10% or more): Dyspnea (14%)

Common (1% to 10%): Rhinitis, bronchitis, cough, laryngospasm, hyperventilation, hay fever

Uncommon (0.1% to 1%): Asthma, pneumonia, epistaxis, hypoventilation, voice alteration

Postmarketing reports: Pulmonary embolus, pleural effusion, carcinoma of lung[Ref]

Hepatic

Postmarketing reports: Cirrhosis of the liver, cholelithiasis hepatomegaly[Ref]

Dermatologic

Very common (10% or more): Rash (19%)

Common (1% to 10%): Hyperhidrosis, pruritus, urticaria, skin disorder, eczema, herpes zoster, pustular rash, skin atrophy, warts

Uncommon (0.1% to 1%): Dry skin, skin hypertrophy, dermatitis, furunculosis, psoriasis, angioedema, contact dermatitis, erythema nodosum, fungal dermatitis, maculopapular rash, pigmentation, benign skin neoplasm, skin carcinoma, skin striae, vesiculobullous rash

Postmarketing reports: Thrombocytopenia[Ref]

Endocrine

Uncommon (0.1% to 1%): Goitre, hyperthyroidism, hypothyroidism[Ref]

Genitourinary

Common (1% to 10%): Vaginal candidiasis, micturition urgency, amenorrhea, hematuria, impotence, menorrhagia, suspicious Papanicolaou smear, urinary frequency, vaginal hemorrhage

Uncommon (0.1% to 1%): Decreased libido, vaginitis, abortion, breast engorgement, breast enlargement, carcinoma in situ cervix, fibrocystic breast, kidney calculus, nocturia, ovarian cyst, priapism, pyelonephritis, abnormal sexual function, urethritis

Postmarketing reports: Urogenital neoplasm, urine abnormality, ovarian carcinoma, nephrosis, breast carcinoma, bladder carcinoma[Ref]

Hypersensitivity

Common (1% to 10%): Hypersensitivity, allergic reaction, anaphylactoid reaction[Ref]

Immunologic

Very common (10% or more): Infection (30%), influenza (14%)

Common (1% to 10%): Abscess

Uncommon (0.1% to 1%): Cellulitis, serum sickness[Ref]

Metabolic

Common (1% to 10%): Weight gain

Postmarketing reports: Hypercholesterolemia[Ref]

Musculoskeletal

Very common (10% or more): Back pain (12%)

Common (1% to 10%): Chills

Uncommon (0.1% to 1%): Lipoma, arthritis, muscle atrophy, bone pain, bursitis, muscle disorder, myopathy, osteomyelitis, tendon pain, tenosynovitis

Postmarketing reports: Systemic lupus erythematosus (SLE), rheumatoid arthritis, generalized spasm[Ref]

Nervous system

Very common (10% or more): Pain (20%)

Common (1% to 10%): Tremor, migraine, syncope, speech disorder

Uncommon (0.1% to 1%): Convulsion, hypokinesia, coma, facial paralysis, myoclonus, neuralgia, paraplegia

Postmarketing reports: Hydrocephalus, myelitis, meningitis, CNS neoplasm, cerebrovascular accident, brain edema, neuralgia[Ref]

Ocular

Common (1% to 10%): Eye disorder, diplopia, visual field defect

Uncommon (0.1% to 1%): Photosensitivity, dry eyes, otitis externa, ptosis, cataract, corneal ulcer, mydriasis, optic neuritis, photophobia

Postmarketing reports: Glaucoma, vision loss[Ref]

Oncologic

Common (1% to 10%): Benign neoplasm of skin

Postmarketing reports: Lymphoma-like reaction, acute leukemia[Ref]

Other

Very common (10% or more): Asthenia (22%)

Common (1% to 10%): Edema, face edema, peripheral edema

Uncommon (0.1% to 1%): Aphasia, ataxia, taste loss[Ref]

Psychiatric

Very common (10% or more): Anxiety (13%)

Common (1% to 10%): Nervousness, abnormal dreams, emotional lability, stupor

Uncommon (0.1% to 1%): Suicide attempt, depersonalization, hallucinations, hostility, concentration disorder, manic reaction, memory impairment, paranoid reaction, psychotic depression, transient stupor[Ref]

Renal

Uncommon (0.1% to 1%): Kidney pain, kidney calculus

Postmarketing reports: Kidney failure[Ref]

Frequently asked questions

References

1. Product Information. Copaxone (glatiramer). Teva Pharmaceuticals USA. 2001;PROD.

2. Cerner Multum, Inc. UK Summary of Product Characteristics.

3. Pharmaceutical Society of Australia. APPGuide online. Australian prescription products guide online. http://www.appco.com.au/appguide/default.asp 2006.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.